| 000 | 03556nam a22003855i 4500 | ||
|---|---|---|---|
| 001 | 82054 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040353.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150311s2015 xxu| s |||| 0|eng d | ||
| 020 | _a9781493920471 | ||
| 024 | 7 |
_a10.1007/978-1-4939-2047-1 _2doi |
|
| 050 | 4 |
_aRC257 _b2015 EB |
|
| 245 | 1 | 0 |
_aTargeted Therapies for Solid Tumors : _bA Handbook for Moving Toward New Frontiers in Cancer Treatment _cedited by Antonio Russo, Rafael Rosell, Christian Rolfo. |
| 260 |
_aNew York, NY _bSpringer New York _bImprint: Humana Press _c2015. |
||
| 300 |
_a1 recurso en línea (X, 269 páginas) _b29 ilustraciones, 23 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aCurrent Clinical Pathology _x2197-781X |
|
| 505 | 0 | _aIntroduction -- Oncogene Addiction in Solid Tumors -- Pharmacology and Clinical Development of New Molecularly Targeted Agents -- Biomarkers as Prognostic, Predictive and Surrogate Endpoints -- Evaluation of Response in Malignant Tumors Treated with Targeted Agents -- Targeted Therapies for HER2-Positive Breast Cancer -- Role of PARP Inhibitors in Triple Negative Breast Cancer (TNBC) -- Targeted Therapies in Squamous Cell Carcinoma of the Head and Neck -- Targeted Therapies for NSCLC -- Targeted Therapies for Gastric Cancer -- Targeted Therapies for Pancreatic Cancer -- Targeted Therapies in Hepatocellular Carcinoma -- Targeted Therapies for Colorectal Cancer -- Targeted Therapy in Gastrointestinal Stromal Tumors -- Targeted Therapies in Kidney Cancer -- Targeted Therapies in Melanoma -- Targeted Therapies for Prostate Cancer -- Targeted Therapies for Bone Metastases. | |
| 520 | 3 | _aThis volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical development of new molecularly targeted agents, the use of biomarkers as prognostic, predictive and surrogate endpoints, and the evaluation of tumor response and specific malignancies treated with targeted agents. The book also covers some of the newest developments in cancer therapy that are not adequately covered by any current available literature. Written by recognized experts in the field, Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer TreatmentÂ{u0CAF}vides a unique and valuable resource in the field of molecular oncology, both for those currently in training, and for those already in clinical or research practice. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aPatología _2embne _9138489 |
|
| 650 | 2 | 7 |
_aPatología _2embne _9138489 |
| 700 | 1 |
_aRusso, Antonio _eeditor literario _918965 _0comprobar BNE19923146307 |
|
| 700 | 1 |
_aRosell, Rafael _eeditor literario _994708 _0Local |
|
| 700 | 1 |
_aRolfo, Christian _eeditor literario _994709 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-2047-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12906931 _b10-10-17 _c10-02-16 |
||
| 988 | _aSpringer_Medicine_2015 | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h0 |
||
| 945 |
_aRC257 .T374 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11574628 _z06-04-17 |
||
| 999 |
_c82054 _d82054 _x1 |
||